Novozymes A/S (CPH:NSIS.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
424.60
+7.20 (1.72%)
Aug 14, 2026, 4:59 PM CET

Novozymes Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
596.7583.6305.8405.9494.2423.12
Depreciation & Amortization
587.4574.8544.1186.4182.7171.75
Other Amortization
----13.1813.05
Loss (Gain) From Sale of Assets
-----39.26-20.04
Asset Writedown & Restructuring Costs
----3.765.65
Loss (Gain) From Sale of Investments
-----33.340.4
Loss (Gain) on Equity Investments
----0.940.54
Stock-Based Compensation
----17.0710.49
Provision & Write-off of Bad Debts
----2.02-1.88
Other Operating Activities
-12.57.1-101-12.1-23.1226.63
Change in Accounts Receivable
-----44.37-77.2
Change in Inventory
63.863.8183.9--105.8-74.78
Change in Accounts Payable
----71.7969.67
Change in Other Net Operating Assets
46.8-7.887.1-23.1-1.21-1.08
Operating Cash Flow
1,2821,2221,020557.1538.57546.32
Operating Cash Flow Growth
35.00%19.77%83.07%3.44%-1.42%-6.63%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-443.5-409.8-338.3-249.1-371.05-144.04
Sale of Property, Plant & Equipment
2.819.70.80.53.7616.68
Cash Acquisitions
-1,520-1,52014.8-22.7-10.35-219.36
Divestitures
--144.511.835.9-
Sale (Purchase) of Intangibles
-65.2-61-21.5-26.7-17.48-22.73
Investing Cash Flow
-2,026-1,971-199.7-286.2-359.22-369.46

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----25.9542.1
Long-Term Debt Issued
-1,717134.5442287.7288.36
Total Debt Issued
3,4181,717134.5442313.65330.45
Long-Term Debt Repaid
--504.6-539.8-334.7-231.51-186.41
Total Debt Repaid
-1,934-504.6-539.8-334.7-231.51-186.41
Net Debt Issued (Repaid)
1,4841,212-405.3107.382.14144.04
Issuance of Common Stock
33.64437.822.422.0541.56
Repurchase of Common Stock
-69.1-99.9---67.22-201.74
Common Dividends Paid
-667.8-402.7-249.7-379-204.89-197.03
Other Financing Activities
49--86-4.2-0.13-0.13
Financing Cash Flow
829.5753.3-703.2-253.5-168.05-213.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-8.3-8.613.3-7.4-0.817.13
Net Cash Flow
77.7-4.7130.31010.49-29.32

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
838.7811.7681.6308167.51402.27
Free Cash Flow Growth
37.13%19.09%121.30%83.87%-58.36%-15.92%
Free Cash Flow Margin
19.97%19.52%17.78%12.82%7.10%20.00%
Free Cash Flow Per Share
1.801.742.451.110.601.44
Levered Free Cash Flow
813.16771.78464.96283.3477.29266.03
Unlevered Free Cash Flow
849.16814.46512.71287.485.86274.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
72.966.476-17.616.99
Cash Income Tax Paid
185.2185.4300.2106122.3484.33
Change in Working Capital
110.656271-23.1-79.59-83.39